StockData
ADVBNasdaqServices-Medical LaboratoriesFiscal year ends June 30

Advanced Biomed Inc.

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Oct 13, 2026
$4.16+0.18 (+4.52%)

Close on Oct 19, 2026

Market cap
$6.51M
P/E (TTM)
0.8
Dividend yield
–

SEC filings

26 of Advanced Biomed's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Annual report10-KJun 30, 2026Oct 13, 2026SEC EDGAR
Current report8-KJul 14, 2026Jul 17, 2026SEC EDGAR
Current report8-KJun 30, 2026Jul 1, 2026SEC EDGAR
Current report8-KJun 30, 2026Jun 30, 2026SEC EDGAR
Proxy statementDEF 14AJun 30, 2026Jun 4, 2026SEC EDGAR
Quarterly report10-QMar 31, 2026May 15, 2026SEC EDGAR
Current report8-KApr 28, 2026May 1, 2026SEC EDGAR
Current report8-KApr 13, 2026Apr 14, 2026SEC EDGAR
Current report8-KApr 2, 2026Apr 3, 2026SEC EDGAR
Current report8-KMar 25, 2026Mar 30, 2026SEC EDGAR
Current report8-KMar 12, 2026Mar 16, 2026SEC EDGAR
Current report8-KFeb 20, 2026Feb 26, 2026SEC EDGAR
Quarterly report10-QDec 31, 2025Feb 13, 2026SEC EDGAR
Current report8-KJan 28, 2026Feb 2, 2026SEC EDGAR
Current report8-KJan 26, 2026Jan 27, 2026SEC EDGAR
Current report8-KJan 16, 2026Jan 21, 2026SEC EDGAR
Current report8-KDec 23, 2025Dec 30, 2025SEC EDGAR
Quarterly report10-QSep 30, 2025Nov 19, 2025SEC EDGAR
Annual report10-KJun 30, 2025Oct 8, 2025SEC EDGAR
Current report8-KSep 19, 2025Sep 19, 2025SEC EDGAR
Current report8-KJul 18, 2025Jul 24, 2025SEC EDGAR
Current report8-KJun 6, 2025Jun 6, 2025SEC EDGAR
Current report8-KMay 23, 2025May 28, 2025SEC EDGAR
Quarterly report10-QMar 31, 2025May 15, 2025SEC EDGAR
Quarterly report10-QDec 31, 2024Apr 15, 2025SEC EDGAR
Current report8-KMar 5, 2025Mar 10, 2025SEC EDGAR